Search
THE CHANGING CLINICAL PERFORMANCE OF DENGUE VIRUS INFECTION IN THE YEAR 2009
Abstract : 216
PDF : 604
Serotype and Clinical Performance of Dengue Virus Infection on the Year 2009
Abstract : 635
PDF : 1129
DIFFERENCES OF UNIVERSAL AND MULTIPLEX PRIMER FOR DETECTION OF DENGUE VIRUS FROM PATIENTS SUSPECTED DENGUE HEMORRHAGIC FEVER (DHF) IN SURABAYA
Abstract : 1833
PDF : 1805
AN APPROPRIATE DIAGNOSIS OF DENGUE VIRUS INFECTION IN SOME CASES WHO HAD AND WERE BEING TREATED IN SOERYA HOSPITAL SEPANJANG – INDONESIA
Abstract : 1016
PDF : 971
THE MONTHLY CHANGING OF THE LOWEST POPULATION DENGUE VIRUS INFECTION IN PATIENT AT SOERYA HOSPITAL SIDOARJO IN 00
Abstract : 182
PDF : 690
ANTIVIRAL ACTIVITY OF COPPER(II)CHLORIDE DIHYDRATE AGAINST DENGUE VIRUS TYPE-2 IN VERO CELL
Abstract : 5247
PDF : 2337
ANTI-DENGUE TYPE 2 VIRUS ACTIVITIES OF ZINC (II) COMPLEX COMPOUNDS WITH 2-(2,4 -DIHYDROXYPHENYL)-3,5,7-TRIHYDROXYCROMEN-4-ONE LIGANDS IN VERO CELLS
Abstract : 2039
PDF : 1110
RNA ISOLATION OF DENGUE VIRUS TYPE 1 WITH DIFFERENT PRECIPITATION SOLVENTS: DIMETHYL SULFOXIDE, ACETONE, AND ETHANOL 70%
Abstract : 3007
PDF : 2172
Knowledge and Attitudes of Dengue Virus Infection Transmission and Its Relationship with Eradication Action Program in Surabaya, Indonesia
Abstract : 1043
PDF : 267
AWARENESS OF USING RINGER LACTAT SOLUTION IN DENGUE VIRUS INFECTION CASES COULD INDUCE SEVERITY
Abstract : 1093
PDF : 2371
Effect of Zinc(II)-2,4,5-triphenyl-1H-imidazole Complex Against Replication DENV-2 in Vero Cell
Abstract : 1513
PDF : 957
INHIBITORY ACTIVITY OF COBALT(II)–MORIN COMPLEX AGAINST THE REPLICATION OF DENGUE VIRUS TYPE 2
Abstract : 1882
PDF : 851
Molecular Surveillance of Dengue Virus Serotype Using Polymerase Chain Reaction in Surabaya 2013
Abstract : 891
PDF : 1008
OVERVIEW OF NUCLEAR FACTOR-KB (NF-KB) AND NON-STRUCTURAL PROTEIN 1 (NS1) IN PATIENTS WITH DENGUE FEVER IN PREMIER HOSPITAL, SURABAYA
Abstract : 1226
PDF : 1329
ANALYSIS ON WHOLE BLOOD, SGOT, SGPT, AND TNF-a EXAMINATION IN PATIENTS WITH NON-DENGUE AND POSITIVE DENGUE FEVER (DF/DHF)
Abstract : 2173
PDF : 4710